Showing all 8 results
Estramustine Phosphate Capsules
FreeEstramustine phosphate capsules typically contain estramustine phosphate sodium as the active medicinal ingredient, along with several inactive excipients to ensure the drug’s stability and delivery.
Imatinib Capsules
FreeImatinib capsules contain the active oncology drug and a specific set of inactive ingredients designed to stabilize the compound for oral delivery.
Lenalidomide Capsules
FreeLenalidomide capsules (brand name Revlimid) are a potent immunomodulatory medication used to treat certain types of cancers, such as multiple myeloma and myelodysplastic syndromes.
Sorafenib Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Film-Coated Tablet, packed in highly secure, child-resistant Alu-Alu blister strips or heavy-gauge HDPE bottles to ensure the absolute stability of the tosylate salt formulation.
Active Ingredient Strength Primary Clinical Function Sorafenib Tosylate INN/Ph.Eur. 200 mg (Equivalent to Sorafenib free base) Global Standard: Base titration unit for the standard 800 mg daily oncology regimen. Excipients Croscarmellose Sodium / Microcrystalline Cellulose / Hypromellose / Magnesium Stearate Superdisintegrant / Diluent / Film-Coating (Engineered for strict gastric dissolution and reliable systemic bioavailability) Tamoxifen Citrate Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Film-Coated Tablet, packed in highly secure, moisture-resistant Alu-PVC or opaque Alu-Alu blister strips to preserve the integrity of the highly sensitive hormonal API.
Active Ingredient Strength Primary Clinical Use Tamoxifen Citrate USP/Ph.Eur. 10 mg (Equivalent to Tamoxifen Base) Standard divided-dose therapy and specific prophylactic risk-reduction protocols. Tamoxifen Citrate USP/Ph.Eur. 20 mg (Equivalent to Tamoxifen Base) Global Standard: Target once-daily adult maintenance dose for ER+ breast cancer. Excipients Mannitol / Maize Starch / Magnesium Stearate / Croscarmellose Sodium Diluent / Superdisintegrant (Engineered for immediate gastric dispersion and reliable absorption) Tamoxifen Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Uncoated or Film-Coated Tablet, packed in highly secure, moisture-resistant Alu-PVC or opaque Alu-Alu blister strips to preserve the integrity of the highly sensitive hormonal API.
Active Ingredient Strength Primary Clinical Use Tamoxifen Citrate USP/Ph.Eur. 10 mg Standard divided-dose therapy and specific risk-reduction protocols. Tamoxifen Citrate USP/Ph.Eur. 20 mg Global Standard: Target once-daily adult maintenance dose for ER+ breast cancer. Excipients Mannitol / Maize Starch / Magnesium Stearate / Croscarmellose Sodium Diluent / Superdisintegrant (Engineered for immediate gastric dispersion and reliable absorption) Temozolamide Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Hard Gelatin Capsule, packed in highly secure, child-resistant and moisture-resistant Alu-Alu blister strips or heavy-gauge HDPE bottles. We offer the complete range of strengths required for exact, weight-based (Body Surface Area) oncology dosing.
Active Ingredient Strength Primary Clinical Use Temozolomide INN/Ph.Eur. 20 mg Micro-dosing for strict Body Surface Area (BSA) rounding and pediatric protocols. Temozolomide INN/Ph.Eur. 100 mg / 140 mg Standard titration strengths for concurrent radiotherapy and maintenance phases. Temozolomide INN/Ph.Eur. 250 mg High-dose foundation for the 5-day maintenance cycle in adult GBM patients. Excipients Lactose Anhydrous / Colloidal Silicon Dioxide / Sodium Starch Glycolate / Stearic Acid Diluent / Glidant / Superdisintegrant (Engineered for immediate gastric capsule dissolution) Thioguanine Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Scored Tablet, packed in highly secure, moisture-resistant Alu-Alu blister strips or heavy-gauge HDPE bottles, engineered to maintain absolute stability and physical containment of the cytotoxic agent.
Active Ingredient Strength Primary Clinical Use Thioguanine USP/Ph.Eur. 40 mg Standard Adult/Pediatric Dose (Titrated by Body Surface Area or Weight) for AML and ALL. Excipients Lactose Monohydrate / Potato Starch / Magnesium Stearate / Stearic Acid Diluent / Glidant (Engineered for immediate gastric dispersion and precise tablet splitting)
